Reversal of heparin anticoagulation by recombinant platelet factor 4 in humans. (Record no. 7697258)

MARC details
000 -LEADER
fixed length control field 01432 a2200397 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250513040711.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 199505s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0009-7322
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1161/01.cir.91.8.2188
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Dehmer, G J
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 19950504
245 00 - TITLE STATEMENT
Title Reversal of heparin anticoagulation by recombinant platelet factor 4 in humans.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Circulation
Date of publication, distribution, etc. Apr 1995
300 ## - PHYSICAL DESCRIPTION
Extent 2188-94 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial; Clinical Trial, Phase I; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cardiac Catheterization
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Dose-Response Relationship, Drug
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hemodynamics
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Heparin
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Heparin Antagonists
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Platelet Factor 4
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Protamines
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Recombinant Proteins
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Whole Blood Coagulation Time
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Fisher, M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Tate, D A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Teo, S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Bonnem, E M
773 0# - HOST ITEM ENTRY
Title Circulation
Related parts vol. 91
-- no. 8
-- p. 2188-94
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1161/01.cir.91.8.2188">https://doi.org/10.1161/01.cir.91.8.2188</a>
Public note Available from publisher's website

No items available.